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Abstract 
Cholinesterase inhibition is one of the most treatment strategies against Alzheimer's 
disease (AD) where metal accumulation is also strongly associated with pathology of the 
disease. In the current study, we assessed inhibitory effect against acetyl- (AChE) and 
butyrylcholinesterase (BChE) and metal-chelating capacity of twelve diterpenes: 
arucadiol, miltirone, tanshinone IIa, 1-oxomiltirone, cryptotanshinone, 1,2-
didehydromiltirone, 1,2-didehydrotanshinone IIa, 1b-hydroxycryptotanshinone, 15,16- 
dihydrotanshinone, tanshinone I, isotanshinone II, 1(S)-hydroxytanshinone IIa, and 
rosmarinic acid, isolated from Perovskia atriplicifolia and Salvia glutinosa. The compounds 
were tested at 10 µg/mL using ELISA microtiter assays against AChE and BChE. QSAR and 
molecular docking studies have been also performed on the active compounds. 
All of the compounds showed higher [e.g., IC50 = 1.12 ± 0.07 µg/mL for 1,2-
didehydromiltirone, IC50 = 1.15 ± 0.07 µg/mL for cryptotanshinone, IC50 = 1.20 ± 0.03 
µg/mL for arucadiol, etc.)] or closer [1,2-didehydrotanshinone IIa (IC50 = 5.98 ± 0.49 
µg/mL) and 1(S)-hydroxytanshinone IIa (IC50 = 5.71 ± 0.27 µg/mL)] inhibition against BChE 
as compared to that of galanthamine (IC50 = 12.56 ± 0.37 µg/mL), whereas only 15,16-
dihydrotanshinone moderately inhibited AChE (65.17 ± 1.39%). 1,2-Didehydrotanshinone 
IIa (48.94 ± 0.26%) and 1(S)-hydroxytanshinone IIa (47.18 ± 5.10%) possessed the highest 
metal-chelation capacity. The present study affords an evidence for the fact that selective 
BChE inhibitors should be further investigated as promising candidate molecules for AD 
therapy. 
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